We serve Chemical Name:1-Methyl-1H-benzimidazol-7-amine CAS:21577-25-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-Methyl-1H-benzimidazol-7-amine
CAS.NO:21577-25-3
Synonyms:3-methyl-3H-benzoimidazol-4-ylamine;RW4017;3-Methyl-3H-benzimidazol-4-ylamine;1-methyl-1H-1,2,3-triazol-5-amine
Molecular Formula:C8H9N3
Molecular Weight:147.17700
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.84000
Exact Mass:147.08000
LogP:1.73670
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-methyl-3H-benzoimidazol-4-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-methyl-1H-1,2,3-triazol-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-methyl-1H-1,2,3-triazol-5-amine Use and application,RW4017 technical grade,usp/ep/jp grade.
Related News: Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� 1-Methyl-1H-benzimidazol-7-amine manufacturer At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 1-Methyl-1H-benzimidazol-7-amine supplier He pointed out that Taiwan had 10 confirmed cases, versus more than 14,000 in mainland China. 1-Methyl-1H-benzimidazol-7-amine vendor Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 1-Methyl-1H-benzimidazol-7-amine factory Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.
